The long-term objectives of this project are to determine the mechanisms by which interleukin 3 (IL-3) regulates the growth and differentiation of hematopoietic cells. The research focuses on the initial biochemical events that occur following IL-3 binding to its receptor and are based on studies which initially demonstrated a critical role for IL-3-induced tyrosine phosphorylation. Based on these data, and the absence of intrinsic kinase activity associated with the receptor, approaches and reagents were developed to examine the potential role of various cytoplasmic protein tyrosine kinases in IL-3 signaling. These studies demonstrated that the Janus kinase Jak2 and to a lesser extent Jak1, associates with the IL-3 receptor and is activated following ligand binding. More recently, it has been found that, in general, members of the Jak family of kinases are involved in signaling through receptors of the cytokine receptor superfamily. In the first specific aim, approaches are outlined which will establish the functional role for Jak1 and Jak2 in IL-3 signaling through the use of various cell systems and dominant negative approaches. In addition, targeted gene disruption will be used to assess the requirement for Jak1 and Jak2 in normal development and hematopoiesis. In the second specific aim, the applicant will define the functional domains of Jak2 and relate these domains to specific biological responses. These studies will use point mutations, deletions and Jak chimeric proteins in various biological assays. Approaches are also proposed to identify gain of function mutations and to determine if such mutations are oncogenic. Lastly, the functional interplay between various members of the Jak family will be examined. One important consequence of IL-3 signaling is hypothesized to be the activation of genes that participate in both cellular function and mitogenesis. A novel family of transcription factors, termed signal transducers and activators of transcription (Stats), has recently been implicated in many cytokine responses and its members are substrates of the Jaks. In IL-3 signaling, Stat5, and possibly Stat6, are specifically tyrosine phosphorylated and activated. Based on this, the studies proposed in the third specific aim would address the role of Stat5 and Stat6 in IL-3 responses. Functional domains would be identified by mutations, deletions or chimeric proteins. The role of Stat5 and Stat6 in specific aspects of the response to IL-3 will be assessed with dominant negative mutants and targeted gene disruptions. Approaches are also proposed that will begin to identify the genes that are specifically regulated by Stat5 or Stat6. Together, the studies address fundamental questions regarding the biochemical mechanisms by which IL-3 regulates the growth and differentiation of hematopoietic cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK042932-06
Application #
2142645
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1990-08-01
Project End
1999-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Gingras, Sebastien; Earls, Laurie R; Howell, Sherie et al. (2015) SCYL2 Protects CA3 Pyramidal Neurons from Excitotoxicity during Functional Maturation of the Mouse Hippocampus. J Neurosci 35:10510-22
Pelletier, Stephane; Gingras, Sebastien; Howell, Sherie et al. (2012) An early onset progressive motor neuron disorder in Scyl1-deficient mice is associated with mislocalization of TDP-43. J Neurosci 32:16560-73
Funakoshi-Tago, Megumi; Pelletier, Stephane; Moritake, Hiroshi et al. (2008) Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol 28:1792-801
Gingras, Sebastien; Pelletier, Stephane; Boyd, Kelli et al. (2007) Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP). PLoS One 2:e808
Funakoshi-Tago, Megumi; Pelletier, Stephane; Matsuda, Tadashi et al. (2006) Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J 25:4763-72
Pelletier, Stephane; Gingras, Sebastien; Funakoshi-Tago, Megumi et al. (2006) Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol 26:8527-38
Mead, Paul E; Parganas, Evan; Ohtsuka, Shiro et al. (2005) Evi-1 expression in Xenopus. Gene Expr Patterns 5:601-8
Carpino, Nick; Turner, Steve; Mekala, Divya et al. (2004) Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20:37-46
Schuendeln, Michael M; Piekorz, Roland P; Wichmann, Christian et al. (2004) The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol 24:6403-9
Carpino, Nick; Thierfelder, William E; Chang, Ming-shi et al. (2004) Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol 24:2584-92

Showing the most recent 10 out of 72 publications